Meda - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Meda M&A Summary

Meda has acquired 12 companies of its own. A total of 10 acquisitions came from private equity firms. It has also divested 1 asset.

Meda’s largest acquisition to date was in 2014, when it acquired Rottapharm for $3.1B. Meda has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (86%) and medical products (15%).

Meda Ownership

Who owns Meda?

Meda is owned by Viatris. It was acquired on February 10, 2016.

Meda Business Overview

Where is Meda headquartered?

Meda is headquartered in Solna, Sweden.

What is Meda’s revenue?

Meda disclosed revenue of 19,648M SEK for 2015 and 15,352M SEK for 2014.

What sector is Meda in?

Meda is a life science company.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity7
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 10
  • M&A Advisors 2

Meda

Meda AB

Pipers vag 2A,
Solna, 17073
Sweden,
+46 8 630 19 00
www.meda.se

Meda is an operator of an international specialty pharma company that is fully represented in Europe and the US through its own sales organizations in more than 50 countries. Meda’s products are sold in about 120 countries, and where it lacks a sales organization, it markets and sells its products via agents and other pharmaceutical companies. Meda has a diversified geographic footprint with approximately 62 percent of Meda's sales generated in Western Europe (the largest countries being Italy, Germany, France, and Sweden), 19 percent in Emerging Markets (driven by China, Russia, the Middle East, and Thailand) and 17 percent in the U.S. Meda has a network of seven manufacturing facilities in Europe, the U.S. and India. Meda is based in Solna, Sweden.


M&A Summary

Buy vs Sell

Year ≤ '09 '10 '11 '12 '13 '14 T
Buy (0.8/yr) # 3 1 1 - 1 1 7
vol $2.5B $350M $213M $135M $3.1B $6.3B
Sell (0.2/yr) # - - - - - 1 1
  8

Most Recent M&A

Company Date Value Type
Meda Pharmaceuticals, Inc. 2014-09-04 - Divestiture
Somerset, New Jersey · www.meda.us
Rottapharm S.p.A. 2014-07-31 3.1B USD Add-on Acquisition
Monza, Italy · www.rotta.com
Acton Pharmaceuticals, Inc. 2013-08-30 135M USD Add-on Acquisition
Marlborough, Massachusetts · www.actonpharmaceuticals.com
Healthcare Brands International Ltd. 2011-04-21 213M SEK Add-on Acquisition
London, United Kingdom · www.healthcarebrandsinternational.com
Alaven Pharmaceuticals LLC 2010-10-05 350M USD Add-on Acquisition
Marietta, Georgia
MedPointe Pharmaceuticals, Inc. 2007-07-20 800M USD Add-on Acquisition
Somerset, New Jersey · www.medpointeinc.com
VIATRIS GmbH & Co. KG 2005-08-10 845M EUR Add-on Acquisition
Bad Homburg, Germany · www.viatris.com
Viatris GmbH & Co., KG. 2005-08-08 845M EUR Add-on Acquisition
Bad Homburg, Germany
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 6 (86%) 6.1B (97%) 1 (100%) -
Medical Products 1 (14%) 213M (3%) - -
Total 7 $6.3B 1 -

By Geo

State/Country Buy Value Sell Value
United States 3 1.3B 1 -
  New Jersey 1 800M 1 -
  Massachusetts 1 135M - -
  Georgia 1 350M - -
Germany 2 1.7B - -
Italy 1 3.1B - -
United Kingdom 1 213M - -
Domestic - - - -
Cross-border 7 (100%) 6.3B (100%) 1 (100%) -
Total 7 $6.3B 1 -

Top M&A Advisors

Financial Deals
Rothschild Global Advisory
 1
Legal Deals
Reed Smith
 1

Deal Values

buy # Total
> $1B 1 $3.1B
$100M to $1B 6 $3.2B
TOTAL $6.3B
Largest Rottapharm S.p.A.
$3.1B (2014-07-31)

M&A Connections

Deals
Acquired from
Investor(s)
71%
5 (71%)
Divested to
Strategic(s)
100%
1 (100%)

Company Summary

SECTOR

Life Science

Revenue

19,648   28% 2015
15,352   18% 2014
13,114   1% 2013
12,991   2% 2012
12,856   2011
(millions of SEK) Show More Show Less

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Meda

Life Science Companies , Sweden Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Sweden Companies

Largest Sweden Companies , Acquisitive Sweden Companies , Recently Acquired Sweden Companies , Recently Sold Sweden Companies , Private Sweden Companies , Public Sweden Companies , Acquired Sweden Companies , PE Backed Sweden Companies
Mergr

Product

Company

Legal